Max Krummel's talk at #AACRio26 quietly reframed how we think about myeloid cell surveillance. bit.ly/4sjXuoL
3
0
0
1
Hashtag
#AACRio26
Advertisement · 728 × 90
Lili Yang's talk at #AACRio26 showed how her team discovered that the entire serotonin recycling pathway — normally associated with neurons — is active in tumor-infiltrating T cells. Serotonin produced after antigen stimulation acts as a brake on T cell activation.
bit.ly/4sjXuoL
1
0
0
0
At #AACRio26, Phil Greenberg revealed why T cells fail in pancreatic tumors — and the clever strategies his team is using to fight back.
bit.ly/4sjXuoL
0
0
0
0
From mutant mice to meaningful signals: Read about Nobel laureate Fred Ramsdell’s #AACRIO26 keynote on regulatory T cells and immune tolerance on the #AACRBlog: buff.ly/N6PBOS4 #AACRBlog
2
2
0
0
Cancer vaccines are here, and research is identifying how to push T cells even further so they thrive in the tumor microenvironment. Learn more about the opening‑night #AACRIO26 keynote addresses from #AACRFellows Elizabeth Jaffee and Philip Greenberg on the #AACRBlog: buff.ly/uKglwKq
9
5
0
1
Attending #AACRIO26? Visit AACR Booth 100 to pick up copies of the inaugural editorial from Cancer Immunology Research Editors-in-Chief Elizabeth M. Jaffee, MD, FAACR, and Antoni Ribas, MD, PhD, FAACR. buff.ly/tD89J7w
1
0
0
0
Former AACR President Elizabeth Jaffee, MD, FAACR, highlights how #AACRio26 brings together immunologists and others from across the cancer research community to accelerate progress in immuno-oncology for the benefit of patients everywhere. buff.ly/CpEPTjI #AACRFellows
2
1
0
0
Attending #AACRIO26? Read this collection of articles that highlights cutting-edge basic science discoveries, translational research advances, and clinical trials aimed at addressing tumor–immune and therapeutic resistance issues and expanding the reach of immuno-oncology. buff.ly/jlGPCHY
3
1
0
0
Regulation of Immune Response to Cancer: Padmanee Sharma and Patrick Hogan addressed this topic in a major symposium at the AACR IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO26 @pamsharmamdphd.bsky.social
3
1
0
0
Renato Ostuni, Robert M. Samstein, and Thornton Thompson discussed "Immune Suppressive Myeloid Cells" in a major symposium at the AACR IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO26 @ostunilab.bsky.social
1
1
0
0
AACR Immuno-Oncology Conference cochair Antoni Ribas discusses what makes #AACRio26 unique, what he's excited about in the field, and the impact of immunotherapy on patients with cancer. buff.ly/ohArRho
3
2
0
0
Join Karen Honey, PhD, Executive Editor of Cancer Immunology Research, and Tali Lev, PhD, Senior Editor of Cancer Discovery, at AACR Booth 100 from 12:30 PM – 1:30 PM today to learn about publishing your research in the journals. #AACRIO26
2
0
0
0
We are presenting our work today at #AACRIO26 in LA. Join Dr. Ibel Carri for a discussion on how to identify noncanonical neoantigens from the dark genome, expanding the landscape of potential immunotherapy targets curated in our database.
Poster Session B
Time: 12:15 PM
Poster ID: LB-B007
1
0
0
0
Tali Lev, PhD, Senior Editor of Cancer Discovery, is attending @theaacr.bsky.social IO Conference on Discovery and Innovation in Cancer Immunology and would love to hear about your research. Connect with her to discuss publishing opportunities in the journals. #AACRIO26
1
0
0
0
Elizabeth M. Jaffee announced that the "The Cancer Vaccine Era Has Arrived" and Philip D. Greenberg discussed "Taking T Cells Where Natural Evolution Hasn’t" during a special keynote session to open the IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO26
25
5
1
1
#AACRIO26 chairs Nina Bhardwaj and Antoni Ribas welcome attendees to the AACR IO Conference on Discovery and Innovation in Cancer Immunology this evening in Los Angeles.
7
1
0
0
Attending #AACRIO26? Stop by AACR Booth 100 to pick up a copy of the February issue of Cancer Immunology Research. buff.ly/1VBiUJH
1
0
0
0
Karen Honey, PhD, Executive Editor of Cancer Immunology Research, is attending @theaacr.bsky.social IO Conference on Discovery and Innovation in Cancer Immunology and would love to hear about your research. Connect with her to discuss publishing opportunities in the journals. #AACRIO26
1
0
0
0
The second edition of this important conference will showcase cutting-edge basic, translational, and clinical research in immunology, inflammation, and immunotherapies for cancer. We thank the #AACRIO26 chairs, Antoni Ribas and Nina Bhardwaj, for developing an outstanding program.
1
0
0
0
The 2026 AACR IO Conference on Discovery and Innovation in Cancer Immunology opens today in Los Angeles with educational sessions followed by keynote addresses from former AACR Presidents and #AACRFellows Elizabeth Jaffee and Philip D. Greenberg. #AACRIO26
3
1
1
0
We are looking forward to meeting our readers at #AACRIO26 next week. Come and say Hi! at our table.
2
0
0
0
Thank you, Dr. Bhardwaj, for your leadership with Dr. Ribas and the program committee in developing a tremendous program for #AACRIO26.
1
0
0
0
As Elizabeth M. Jaffee and Antoni Ribas take over as the new editors-in-chief of Cancer Immunology Research, they share how they got started in immunotherapy research, their vision for the AACR journal, and what excites them about #AACRIO26 on the #AACRBlog: buff.ly/2QY3kFY
7
2
0
0
Submit a clinical trial or late-breaking abstract by January 20 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/bb9lwPV
#AACRIO26
2
2
0
0
Submit a clinical trial or late-breaking abstract by January 20 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/bb9lwPV
#AACRIO26
2
1
0
0
Register by January 9 to get the lowest rates for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/bb9lwPV
#AACRIO26 @BhardwajLab
0
1
0
0
Register by January 9 to get the lowest rates for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/bb9lwPV
#AACRIO26 @BhardwajLab
0
2
0
0
Register by January 9 to get the lowest rates for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/bb9lwPV
#AACRIO26 @BhardwajLab
0
3
0
0
Register by January 9 to get the lowest rates for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/bb9lwPV
#AACRIO26 @BhardwajLab
0
1
0
0
Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/TUarANa
#AACRIO26
0
1
0
0